טוען...
ATR inhibition sensitizes HPV(−) and HPV(+) head and neck squamous cell carcinoma to cisplatin
OBJECTIVES: Cisplatin is commonly used in the treatment of head and neck squamous cell carcinoma (HNSCC), and the repair of cisplatin-induced DNA damage involves activation of the DNA damage response protein ataxia telangiectasia and Rad3-related (ATR). Resistance to cisplatin therapy exacerbates ad...
שמור ב:
| הוצא לאור ב: | Oral Oncol |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6827881/ https://ncbi.nlm.nih.gov/pubmed/31345392 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.oraloncology.2019.05.028 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|